Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Biocon Ltd. Capital/Financing Update 2026

Jan 14, 2026

61176_rns_2026-01-14_34ab3b2f-750f-477f-a062-2d7a9fe7fda2.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [132 x 52] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423

CIN : L24234KA1978PLC003417

www.biocon.com

BIO/SECL/EA/2025-26/161

January 14, 2026

January 14, 2026
To
The Manager,
BSE Limited
Department of Corporate Services
Phiroze Jeejeebhoy Towers,
Dalal Street, Mumbai–400 001
To
The Manager,
National Stock Exchange of India Limited
Corporate Communication Department
Exchange Plaza, Bandra Kurla Complex
Mumbai–400 050
Scrip Code- 532523 Scrip Symbol– BIOCON

Dear Sir/ Madam,

Subject: Qualified Institutions Placement of equity shares of face value ₹ 5 each (“Equity Shares”) (such placement, the “Issue”) by Biocon Limited (the “Company”) under Chapter VI of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (the “SEBI ICDR Regulations”) and Sections 23(1)(b), 42 and 62(1)(c) of the Companies Act, 2013, as amended.

In furtherance to our letter dated January 12, 2026 and January 14, 2026, we wish to inform you that the Fund Raising Committee at its meeting held today i.e. January 14, 2026, has approved and adopted the Placement Document dated January 14, 2026, in connection with the Issue.

The meeting of the Fund Raising Committee commenced at 10:12 p.m. and concluded at 10:20 p.m.

We request you to kindly take this on records and treat the same as compliance under Regulation 30 and other applicable regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.

Copy of this intimation is being also made available on the website of the Company at www.biocon.com.

Kindly take the same on record and acknowledge.

Thanking You,

Yours faithfully,

For Biocon Limited

RAJESH Digitally signed by RAJESH UMAKANT UMAKANT SHANOY Date: 2026.01.14 SHANOY 22:27:26 +05'30'

___

Rajesh U. Shanoy Company Secretary and Compliance Officer ICSI membership number: A16328